GIHN || Breaking News

FDA approves Viberzi and Xifaxan for IBS

Posted on: 28/05/2015 - 18:42

The Food and Drug Administration has approved Viberzi (eluxadoline) and Xifaxan (rifaximin) to treat irritable bowel syndrome with diarrhea (IBS-D) in adults, the agency announced May 27. Viberzi is...

Field of Interest: Gastroentero...
Type: News Item

Liver transplant exceptions deserve fresh look

Posted on: 01/05/2014 - 05:01

Room air hypoxemia was associated with greater post–liver transplant mortality in hepatopulmonary syndrome patients, according to Dr. David S. Goldberg and his colleagues. On the other hand, HPS...

Field of Interest: Gastroentero...
Type: News Item

Anti-TNFs equal in Crohn’s disease

Posted on: 01/05/2014 - 05:01

There is no significant difference between infliximab and adalimumab in Crohn’s disease, reported Dr. Mark T. Osterman and his colleagues in the May 1 issue of Clinical Gastroenterology and...

Field of Interest: Gastroentero...
Type: News Item

Budesonide safe, effective for microscopic colitis

Posted on: 01/05/2014 - 05:01

Oral budesonide is effective and safe for short-term treatment of collagenous colitis. Indeed, the finding supports the recent recommendation by the European Microscopic Colitis Group to make...

Field of Interest: Gastroentero...
Type: News Item

Liver histology crucial at Wilson disease diagnosis

Posted on: 01/04/2014 - 05:01

Wilson disease patients without cirrhosis at diagnosis generally have good long-term prognoses, but the presence of cirrhosis on diagnosis of this rare condition necessitates transplant in up to 13%...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More